Hear firsthand what communications specialists have to say in podcasts and audio blogs produced by — or affiliated with — members of our agency.
Former Food and Drug Administration Commissioner Dr. David Kessler sits down with pharma industry communications specialist Mark Senak to discuss challenges facing the FDA. Dr. Kessler also explains why there are "serious questions about the credibility of the agency."
Listen: A Conversation With Former FDA Commissioner David Kessler
Members of Fleishman-Hillard's International Advisory Board gathered in Washington, D.C., to discuss the numerous challenges facing the upcoming administration. Former White House Chiefs of Staff Leon Panetta and Andrew Card sat down with Fleishman-Hillard President and CEO Dave Senay to talk about their experiences from those initial 100 days in office and offer priorities for 2009 and beyond.
Listen: Interviews with Members of Fleishman-Hillard's International Advisory Board
Surprisingly, many companies going public miscalculate the time it takes and the expectations that are created. This two-part series on PR and investor relations wraps up with communications specialists from Beyond the Hype discussing the best way to manage public relations during an initial public offering.
Listen: PR/IR Conversation (Part 2 of 2)
Having a better understanding of an organization's regulations is just one way for PR professionals to get more storytelling into financial announcements. Communications strategists from Beyond the Hype take a look at the inherent synergies and common obstacles that exist between PR and investor relations.
Listen: PR/IR Conversation (Part 1 of 2)
True to its innovative roots, this year's DEMO technology conference introduced several buzz-worthy concepts. Join communications strategists from Beyond the Hype as they discuss conference highlights, offer advice for future attendees, and discuss a security product that claims to root out evil in technology.
At this year’s International Air Transport Association (IATA) meeting — the industry’s largest annual gathering — the focus was on the environmental challenges facing today’s industry. Join Brussels-based communications specialist Nick Andrews as he moderates “The Environment Challenge.”
Watch: The Environment Challenge
Mark Senak, pharma industry communications specialist, talks with Patrick Clinton, editor-in-chief of Pharmaceutical Executive magazine, about the impact of negative publicity on the Food and Drug Administration and the pharmaceutical industry.
Listen: A Conversation With Pharmaceutical Executive’s Editor-in-Chief
Andrew Jack, pharmaceutical correspondent with the Financial Times, sits down with pharma industry communications specialist Mark Senak to discuss the FDA’s influence over approvals in Europe and whether the agency’s woes are affecting the European Medicines Agency (EMEA).
Listen: A Conversation With Financial Times’ Pharmaceutical Correspondent Andrew Jack
Crisis communications are like air bags: You never want to use them but are sure glad they’re available. A company needs to be careful to make the right moves when the community in which it resides faces a major problem. Crisis communications specialist Jane Shapiro discusses how preparing for and reacting to a pandemic can help a company maintain its reputation.
Listen: Jane Shapiro Speaks on Pandemic Planning to the Canadian Association of University Business Officers
Fleishman-Hillard’s London-based One-Stop-Shop hosts this lively debate that focuses on several issues affecting the healthcare industry. What, and who, are the industry’s driving forces? Is regulation needed? And what about ethics within the industry?
Creativity helps. Research and development works too; implementation is necessary. But those are all just cogs in the innovation machine. Innovation specialist Kathie Thomas breaks down how the innovation concept helps companies to put the best product out to its customers.